🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery ◆ GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons ◆ Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing ◆ Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery ◆ GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons ◆ Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing ◆
Updated 06 Sep 2026 · ClinicalTrials.gov

Clinical Trials in Dublin

← All Irish trials

Every active and recruiting clinical study with an Irish site — searchable by condition, sponsor, phase and location. Refreshed daily from the ClinicalTrials.gov registry.

43
Recruiting now
75
Active studies
Starting soon Phase 3
Long-term Extension Study to Evaluate Safety and Tolerability of Admilparant in Participants With Pulmonary Fibrosis
Pulmonary Fibrosis
Bristol-Myers Squibb · started 2026-12-16
Tallaght · Drogheda · Dublin
NCT07441408 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
Myelodysplastic Syndrome, Anemia
Takeda · started 2026-05-21
Cork · Dublin · Galway
NCT07422480 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
Alpha 1 Antitrypsin Deficiency
Grifols Therapeutics LLC · started 2026-05-05
Dublin
NCT07555483 on ClinicalTrials.gov ↗
Recruiting
Bimodal Electrical-Sound Stimulation and Auditory Training for Chronic Tonal Tinnitus
Tinnitus, Subjective, Tinnitus, Chronic Tinnitus
University of Dublin, Trinity College · started 2026-01-30
Dublin
NCT07393880 on ClinicalTrials.gov ↗
Recruiting
A Smart Phone Application to Improve Adoption of the 2024 Kidney Disease Improving Global Outcomes (KDIGO) Chronic Kidney Disease (CKD) Guidelines
Chronic Kidney Disease, Proteinuria, Blood Pressure Control, Congenital Anomalies of the Kidneys and Urinary Tract
St. James's Hospital, Ireland · started 2026-01-14
Dublin
NCT07561957 on ClinicalTrials.gov ↗
Active Phase 2/Phase 3
A Study Comparing Navlimetostat (BMS-986504) in Combination With Nab-paclitaxel and Gemcitabine Versus Placebo in Combination With Nab-paclitaxel and Gemcitabine in Participants With Untreated Metastatic Pancreatic Ductal Adenocarcinoma With Homozygous MTAP Deletion (MountainTAP-30)
Pancreatic Ductal Adenocarcinoma
Bristol-Myers Squibb · started 2025-10-23
Dublin
NCT07076121 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
Ovarian Neoplasms, Fallopian Tube Neoplasms, Peritoneal Neoplasms, Neoplasm Metastasis
Eli Lilly and Company · started 2025-10-22
Cork · Dublin
NCT07213804 on ClinicalTrials.gov ↗
Recruiting Phase 1
A Study of ZW251 in Participants With Advanced Solid Tumors
Hepatocellular Carcinoma, Squamous Cell Non-Small Cell Lung Cancer, Germ Cell Tumor
Zymeworks BC Inc. · started 2025-10-21
Dublin
NCT07164313 on ClinicalTrials.gov ↗
Recruiting Phase 2/Phase 3
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
Urothelial Cancer
Bristol-Myers Squibb · started 2025-09-30
Cork · Dublin
NCT07106762 on ClinicalTrials.gov ↗
Recruiting
Pre-infusion Aerobic Cycling Exercise for CardioRespiratory Fitness in Cancer Patients
Cancer
University of Dublin, Trinity College · started 2025-09-24
Dublin
NCT07182773 on ClinicalTrials.gov ↗
Recruiting Phase 2
Usnoflast Neuromuscular Investigation for Treatment Efficacy in Amyotrophic Lateral Sclerosis
Amyotrophic Lateral Sclerosis (ALS)
Zydus Therapeutics Inc. · started 2025-09-17
Dublin
NCT07023835 on ClinicalTrials.gov ↗
Recruiting
Harmony TPV EMEA PMS
Severe Pulmonary Valve Regurgitation
Medtronic Cardiovascular · started 2025-07-30
Dublin
NCT06906926 on ClinicalTrials.gov ↗
Recruiting Phase 1/Phase 2
A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)
Castration-Resistant Prostatic Cancer, Metastasis
Merck Sharp & Dohme LLC · started 2025-07-03
Dublin
NCT06863272 on ClinicalTrials.gov ↗
Active Phase 2
A Study to Assess the Efficacy and Safety of Verekitug in Participants With COPD
Chronic Obstructive Pulmonary Disease
Upstream Bio Inc. · started 2025-07-02
Dublin · Tallaght · Drogheda
NCT06981078 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
Endometrial Cancer
Merck Sharp & Dohme LLC · started 2025-05-22
Dublin · Cork
NCT06952504 on ClinicalTrials.gov ↗
Recruiting
The Lung Health Check Pilot
Non-Small Cell Lung Cancer
Royal College of Surgeons, Ireland · started 2025-05-19
Dublin
NCT07099027 on ClinicalTrials.gov ↗
Active Phase 2
A Dose-Finding Study of Tebapivat to Assess Efficacy, and Safety in Participants With Sickle Cell Disease (SCD)
Sickle Cell Disease
Agios Pharmaceuticals, Inc. · started 2025-05-01
Dublin
NCT06924970 on ClinicalTrials.gov ↗
Recruiting
EXtubation Related Complications - the EXTUBE Study (EXTUBE)
Extubation
University Health Network, Toronto · started 2025-04-14
Castlebar · Cork · Dublin · Galway · Waterford
NCT06442930 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer
Merck Sharp & Dohme LLC · started 2025-04-09
Dublin
NCT06824467 on ClinicalTrials.gov ↗
Recruiting
Assessing Intellectual and Motor Outcomes in High-risk Infants
Cerebral Palsy, Cerebral Palsy (CP), Cerebral Palsy Children, High-risk Infants
University College Cork · started 2025-03-21
Cork · Dublin
NCT06857539 on ClinicalTrials.gov ↗
Active Phase 3
Study of Eftilagimod Alfa (Efti) in Combination With Pembrolizumab and Chemotherapy Versus Placebo in Combination With Pembrolizumab and Chemotherapy in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC) (TACTI-004)
Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
Immutep S.A.S. · started 2025-03-21
Cork · Dublin
NCT06726265 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease
Crohn's Disease
Takeda · started 2025-01-02
Dublin
NCT06227910 on ClinicalTrials.gov ↗
Recruiting Phase 3
Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain
Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Metastatic Digestive System Carcinoma, Metastatic Lung Non-Small Cell Carcinoma
NRG Oncology · started 2024-12-12
Dublin · Galway · Cork
NCT06500455 on ClinicalTrials.gov ↗
Active Phase 2
A Clinical Trial to Learn About the Effects of VHB937 in People With Amyotrophic Lateral Sclerosis (ALS)
Amyotrophic Lateral Sclerosis (ALS)
Novartis Pharmaceuticals · started 2024-10-17
Dublin
NCT06643481 on ClinicalTrials.gov ↗
Recruiting Phase 2
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
Ulcerative Colitis, Ulcerative Colitis Chronic
Eli Lilly and Company · started 2024-10-10
Dublin
NCT06598943 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
Non-small Cell Lung Cancer
Bristol-Myers Squibb · started 2024-10-07
Dublin
NCT06561386 on ClinicalTrials.gov ↗
Recruiting
A Prospective Study of the Genomic Landscape of Central Nervous System Disease Secondary to Breast Cancer Utilising Cell-free DNA Derived From Cerebrospinal Fluid (CSF)
Breast Cancer
Royal College of Surgeons, Ireland · started 2024-10-01
Dublin
NCT07503704 on ClinicalTrials.gov ↗
Active Phase 3
Evaluation of Efficacy of Povetacicept in Adults With Immunoglobulin A Nephropathy (IgAN)
Immunoglobulin A Nephropathy
Alpine Immune Sciences Inc, A Subsidiary of Vertex · started 2024-08-30
Cork · Dublin · Galway · Waterford
NCT06564142 on ClinicalTrials.gov ↗
Active Phase 3
A Study to Compare Sacituzumab Tirumotecan (MK-2870) Monotherapy Versus Treatment of Physician's Choice as Second-line Treatment for Participants With Recurrent or Metastatic Cervical Cancer (MK-2870-020/TroFuse-020/Gog-3101/ENGOT-cx20)
Cervical Cancer
Merck Sharp & Dohme LLC · started 2024-07-24
Cork · Dublin
NCT06459180 on ClinicalTrials.gov ↗
Recruiting Phase 3
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Triple-Negative Breast Cancer
Merck Sharp & Dohme LLC · started 2024-06-24
Cork · Dublin · Galway
NCT06393374 on ClinicalTrials.gov ↗
By invitation
Prostate Cancer Awareness and Initiative for Screening in the European Union
Prostate Cancer
European Association of Urology Research Foundation · started 2024-06-01
Dublin
NCT06424275 on ClinicalTrials.gov ↗
Recruiting
Effect of L-PRF on Implant Stability and Marginal Bone Levels.
Dental Implant, Implant Stability, Marginal Bone Levels, L-PRF
Dublin Dental University Hospital · started 2024-06-01
Dublin
NCT06516263 on ClinicalTrials.gov ↗
Starting soon
Evaluating a Targeted Selective Speech, Language, and Communication Intervention at Scale - Protocol for the 'Happy Talk' Cluster Randomised Controlled Trial.
Developmental Language Disorder and Language Impairment, Deprivation
University College Cork · started 2024-06
Dublin · Galway · Wexford · Wicklow
NCT06460090 on ClinicalTrials.gov ↗
Recruiting
Exploring the Impact of a Multi-modal Nutritional Intervention in Patients Undergoing Chemotherapy for Pancreatic Cancer (FEED Trial)
Pancreatic Cancer
Cancer Trials Ireland · started 2024-05-01
Dublin
NCT06149546 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
Breast Neoplasms
Merck Sharp & Dohme LLC · started 2024-04-14
Cork · Dublin
NCT06312176 on ClinicalTrials.gov ↗
Active
Essilor® Stellest® Lenses Multicentre European Study (SLOMES)
Myopia
Essilor International · started 2024-03-22
Dublin
NCT06263946 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Study of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and Newborn (HDFN)
Hemolytic Disease of the Fetus and Newborn
Janssen Research & Development, LLC · started 2023-12-20
Dublin
NCT05912517 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
Metastatic Castration-resistant Prostate Cancer (mCRPC), Prostatic Neoplasms
Merck Sharp & Dohme LLC · started 2023-12-18
Dublin
NCT06136650 on ClinicalTrials.gov ↗
Recruiting
A Study of Clinical Outcomes in Patients With Relapsed/Refractory Multiple Myeloma (RRMM) Treated With T-cell Redirectors Outside of Clinical Trials
Relapsed/Refractory Multiple Myeloma (RRMM)
Janssen-Cilag Ltd. · started 2023-12-18
Cork · Dublin · Galway
NCT06285318 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)
Non-small Cell Lung Cancer
Merck Sharp & Dohme LLC · started 2023-12-06
Dublin
NCT06077760 on ClinicalTrials.gov ↗
By invitation Phase 3
A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Active Idiopathic Inflammatory Myopathy
Myositis, Active Idiopathic Inflammatory Myopathy, Dermatomyositis, Polymyositis
argenx · started 2023-09-12
Dublin
NCT05979441 on ClinicalTrials.gov ↗
Active Phase 3
A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation
Heart Failure
Novo Nordisk A/S · started 2023-05-08
Dublin · Cork · Mahon, Cork
NCT05636176 on ClinicalTrials.gov ↗
Active
Ultimaster Nagomi™ Sirolimus Eluting Coronary Stent System in Complex PCI Patients
Cardiovascular Disease, Coronary Artery Occlusion, Ischemic Heart Disease
Terumo Europe N.V. · started 2023-04-25
Cork · Dublin · Galway
NCT05705973 on ClinicalTrials.gov ↗
Active Phase 3
REDEFINE 3: A Research Study to See the Effects of CagriSema in People Living With Diseases in the Heart and Blood Vessels
Cardiovascular Disease
Novo Nordisk A/S · started 2023-03-01
Galway · Dublin
NCT05669755 on ClinicalTrials.gov ↗
Recruiting Phase 2
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
Metastatic Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8, Stage IV Renal Cell Cancer AJCC v8, Unresectable Renal Cell Carcinoma
NRG Oncology · started 2023-02-01
Dublin
NCT05327686 on ClinicalTrials.gov ↗
Active Phase 3
A Trial to See if the Combination of Fianlimab With Cemiplimab Works Better Than Pembrolizumab for Preventing or Delaying Melanoma From Coming Back After it Has Been Removed With Surgery
Melanoma
Regeneron Pharmaceuticals · started 2023-01-16
Galway · Cork · Dublin
NCT05608291 on ClinicalTrials.gov ↗
Recruiting Phase 1/Phase 2
A Trial of Lu AG13909 in Participants With Congenital Adrenal Hyperplasia
Congenital Adrenal Hyperplasia
H. Lundbeck A/S · started 2022-12-19
Dublin
NCT05669950 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
Relapsed or Refractory Multiple Myeloma
Celgene · started 2022-09-20
Galway · Cork · Dublin · Limerick
NCT05519085 on ClinicalTrials.gov ↗
Recruiting Phase 3
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation
Multiple Myeloma
European Myeloma Network B.V. · started 2022-09-08
Cork · Dublin · Galway · Limerick
NCT05243797 on ClinicalTrials.gov ↗
Active Phase 2
A Study of Zilovertamab Vedotin (MK-2140) as Monotherapy and in Combination in Participants With Aggressive and Indolent B-cell Malignancies (MK-2140-006)
Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Follicular Lymphoma, Richter Transformation Lymphoma
Merck Sharp & Dohme LLC · started 2022-07-21
Dublin
NCT05458297 on ClinicalTrials.gov ↗
Active Phase 2
(Summit) A Study to Evaluate the Efficacy and Safety of CGT9486 Versus Placebo in Patients With Indolent or Smoldering Systemic Mastocytosis
SSM, Mastocytosis, Indolent, Mastocytosis, Systemic, Mastocytosis
Cogent Biosciences, Inc. · started 2022-06-27
Cork · Dublin
NCT05186753 on ClinicalTrials.gov ↗
Active
ProVee Urethral Expander System IDE Study (ProVIDE)
BPH With Symptomatic Lower Urinary Tract Symptoms
ProVerum Medical · started 2022-06-09
Dublin
NCT05186740 on ClinicalTrials.gov ↗
Recruiting
Awareness Detection and Communication in Disorders of Consciousness
Disorder of Consciousness, Paralysis, Motor Neuron Disease, Stroke
University of Ulster · started 2022-02-08
Dublin
NCT03827187 on ClinicalTrials.gov ↗
Active Phase 3
Open-Label Safety Study of Acoramidis (AG10) in Symptomatic ATTR Participants
Amyloid Cardiomyopathy, Transthyretin-Related
Eidos Therapeutics, a BridgeBio company · started 2021-10-27
Dublin
NCT04988386 on ClinicalTrials.gov ↗
Recruiting
Precision Diagnosis and Care for Families With Pulmonary Fibrosis in Ireland
Connective Tissue Diseases, Interstitial Lung Disease, Idiopathic Pulmonary Fibrosis, Familial Idiopathic Pulmonary Fibrosis
Royal College of Surgeons, Ireland · started 2021-09-28
Dublin
NCT06702228 on ClinicalTrials.gov ↗
Recruiting Phase 1/Phase 2
A Beta-only IL-2 ImmunoTherapY Study
Advanced Solid Tumor, Unresectable Solid Tumor, Clear Cell Renal Cell Carcinoma, Triple Negative Breast Cancer
Medicenna Therapeutics, Inc. · started 2021-08-27
Dublin
NCT05086692 on ClinicalTrials.gov ↗
Active Phase 3
A Phase 3 Study to Assess Efficacy and Safety of Tafasitamab Plus Lenalidomide and Rituximab Compared to Placebo Plus Lenalidomide and Rituximab in Patients With Relapsed/Refractory (R/R) Follicular Lymphoma or Marginal Zone Lymphoma.
Follicular Lymphoma, Marginal Zone Lymphoma
Incyte Corporation · started 2021-04-15
Dublin · Galway
NCT04680052 on ClinicalTrials.gov ↗
Recruiting
BoStOn SCientific Rhythm MAnagemenT REgiStry
Cardiac Disease
Boston Scientific Corporation · started 2021-03-31
Dublin
NCT04823663 on ClinicalTrials.gov ↗
Active Phase 3
Phase 3 Study of MRTX849 (Adagrasib) vs Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer With KRAS G12C Mutation
Metastatic Non Small Cell Lung Cancer, Advanced Non Small Cell Lung Cancer
Mirati Therapeutics Inc. · started 2021-02-23
Tallaght · Dublin · Galway · Limerick
NCT04685135 on ClinicalTrials.gov ↗
Recruiting
iCorMicA - Stratified Medicine in Angina
Microvascular Angina, Angina, Stable, Ischemia With No Obstructive Coronary Arteries (INOCA), Coronary Microvascular Dysfunction (CMD)
NHS Greater Glasgow and Clyde · started 2020-12-30
Cork · Dublin
NCT04674449 on ClinicalTrials.gov ↗
Recruiting Phase 2
'SOURCE - LUNG' Stereotactic Ablative Radiation Therapy Of UltRaCEntral LUNG Tumours (SOURCE Lung)
NSCLC/Oligometastatic Cancer (Single Lung Lesion)
Cancer Trials Ireland · started 2020-12-22
Dublin
NCT04375904 on ClinicalTrials.gov ↗
Recruiting Phase 2/Phase 3
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer
Mirati Therapeutics Inc. · started 2020-12-02
Cork · Dublin · Galway · Limerick · Waterford
NCT04613596 on ClinicalTrials.gov ↗
Recruiting Phase 3
Chemoradiotherapy Followed by Planned Surgery or by Surveillance and Surgery Only When Needed for Oesophageal Cancer
Esophageal Squamous Cell Carcinoma
Karolinska University Hospital · started 2020-11-27
Dublin
NCT04460352 on ClinicalTrials.gov ↗
Active Phase 3
A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Crovalimab Versus Eculizumab in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) Currently Treated With Complement Inhibitors
Paroxysmal Nocturnal Hemoglobinuria
Hoffmann-La Roche · started 2020-09-30
Dublin
NCT04432584 on ClinicalTrials.gov ↗
Active Phase 4
Real World Clinical Outcomes With Novel Modulator Therapy Combinations in People With CF (RECOVER)
Cystic Fibrosis, Cystic Fibrosis Liver Disease, Cystic Fibrosis in Children, Adherence, Medication
Royal College of Surgeons, Ireland · started 2020-09-03
Dublin · Limerick · Tallaght
NCT04602468 on ClinicalTrials.gov ↗
Active Phase 3
Darolutamide Augments Standard Therapy for Localised Very High-Risk Cancer of the Prostate
Prostate Cancer
University of Sydney · started 2020-03-31
Rathgar · Cork · Dublin · Galway
NCT04136353 on ClinicalTrials.gov ↗
Active
Paediatric Sjögren Syndrome Cohort Study and Repository (PaedSSCoRe)
Sjogren's Syndrome Childhood-onset
University College, London · started 2020-01-11
Dublin
NCT04762108 on ClinicalTrials.gov ↗
Recruiting
Dundrum Forensic Redevelopment Evaluation Study: D-FOREST Study.
Schizophrenia, Forensic Psychiatry, Outcome Measure, Violence
Health Service Executive, Ireland · started 2019-12-01
Dublin
NCT05074732 on ClinicalTrials.gov ↗
Active Phase 3
HELIOS-B: A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
Transthyretin Amyloidosis (ATTR) With Cardiomyopathy
Alnylam Pharmaceuticals · started 2019-11-26
Dublin
NCT04153149 on ClinicalTrials.gov ↗
Recruiting Phase 2
Preservation of Swallowing in Respected Oral Cavity Squamous Cell Carcinoma: Examining Radiation Volume Effects (PRESERVE): A Randomized Trial
Head and Neck Cancer
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's · started 2019-09-06
Wilton · Galway · Rathgar · Dublin
NCT03997643 on ClinicalTrials.gov ↗
Active Phase 3
Study of Pembrolizumab Given Prior to Surgery and in Combination With Radiotherapy Given Post-surgery for Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-689)
Head and Neck Neoplasms
Merck Sharp & Dohme LLC · started 2018-12-17
Dublin
NCT03765918 on ClinicalTrials.gov ↗
Active
Pyruvate Kinase Deficiency Global Longitudinal Registry
Pyruvate Kinase Deficiency
Agios Pharmaceuticals, Inc. · started 2018-04-23
Dublin
NCT03481738 on ClinicalTrials.gov ↗
Active Phase 3
A Study of Niraparib (GSK3985771) Maintenance Treatment in Participants With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy
Ovarian Neoplasms
Tesaro, Inc. · started 2016-07-11
Dublin · Dunmore RoadWaterford · Galway
NCT02655016 on ClinicalTrials.gov ↗
Active Phase 3
Attachment Inhibitor Comparison in Heavily Treatment Experienced Patients
HIV Infections
ViiV Healthcare · started 2015-02-23
Dublin
NCT02362503 on ClinicalTrials.gov ↗
Active Phase 3
Enzalutamide in First Line Androgen Deprivation Therapy for Metastatic Prostate Cancer
Prostatic Neoplasms
University of Sydney · started 2014-03
Beaumont · Dublin · Galway · Tallaght · Waterford
NCT02446405 on ClinicalTrials.gov ↗
No trials match your search.

Browse by location

Dublin · 75 Cork · 31 Galway · 25 Limerick · 9 Tallaght · 5 Waterford · 5 Beaumont · 3 Drogheda · 2 Crumlin · 2 Rathgar · 2 Wexford · 1 Wicklow · 1

Browse by condition

Prostate Cancer · 3 Breast Cancer · 2 Ulcerative Colitis · 2 Amyotrophic Lateral Sclerosis (AL… · 2 Non-small Cell Lung Cancer · 2 Fallopian Tube Cancer · 2 Multiple Myeloma · 2 Prostatic Neoplasms · 2 Ovarian Neoplasms · 2 Crohn's Disease · 2 Follicular Lymphoma · 2 Cardiovascular Disease · 2 Vascular Diseases · 2
Cite this page

Priya Life Science (2026). Clinical Trials in Ireland Tracker. Available at: https://priyalifescience.com/clinical-trials-ireland/city/dublin (Accessed: 6 September 2026).

Embed this data ↗

Source: ClinicalTrials.gov, U.S. National Library of Medicine — studies listing at least one Irish site, refreshed daily. Listing here is informational and not medical advice; eligibility is determined by each study team. Patients should discuss participation with their clinician. For trials across the wider EU, see our EU Clinical Trials Tracker.